药物对比
Ertugliflozin vs Sotagliflozin
Ertugliflozin（用于2型糖尿病的SGLT2抑制剂，有黑框警告）vs sotagliflozin（用于心力衰竭的双重SGLT1/2抑制剂，无黑框警告）。两者均为口服药，妊娠期见说明书。取决于治疗糖尿病还是心力衰竭。
此页面暂无可用的对比维度。
临床背景
Patients considering SGLT inhibitor therapies for type 2 diabetes or heart failure may compare ertugliflozin and sotagliflozin.
结论
The selection between ertugliflozin and sotagliflozin should be based on the patient's specific medical needs rather than assuming one is superior.
全部药物对比